Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 1979-1982

  Van Gele, M ^a   Van Roy, N ^a   Jauch, A ^d   Laureys, G ^a   Benoit, Y ^a   Schelfhout, V ^a   De Potter, C R ^a   Brock, P ^b   Uyttebroeck, A ^b   Sciot, R ^b   Schuuring, E ^c   Versteeg, R ^e   Speleman, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c LEIDEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e NONE

Author keywords

Childhood; Comparative genomic hybridisation; Genetic imbalances; Genetics; Neuroblastoma

Indexed keywords

CHROMOSOME 1; CHROMOSOME 17Q; CONFERENCE PAPER; GENE DELETION; GENE DUPLICATION; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; HUMAN CELL; KARYOTYPING; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; TARGET CELL;

CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 17; GENE AMPLIFICATION; GENES, MYC; HUMANS; MALE; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0031418167     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00289-X     Document Type: Conference Paper

References (25)

1. Brodeur G. M., Fong C. T. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet. 41:1989;153-174.
2. Fong C., White P. S., Peterson K., et al. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res. 52:1992;1780-1785.
3. Srivatsan E. S., Ying K. L., Seeger R. C. Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chrom Cancer. 7:1993;32-37.
4. Savelyeva L., Corvi R., Schwab M. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet. 5:1994;334-340.
5. Van Roy N, Laureys G, Ching Cheng N, et al. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumor and cell lines. Genes Chrom Cancer 1994, 10, 103-114.
6. Van Roy N., Cheng N. C., Laureys G., et al. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma. Eur J Cancer. 31A:(4):1995;530-535.
7. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-MYC oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313, 1111-1116.
8. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridisation for molecular cytogenetic analysis of solid tumors. Science 1992, 258, 818-821.
9. du Manoir S, Speicher MR, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridisation. Hum Genet 1993, 90, 590-610.
10. Speicher MR, du Manoir S, Schröck E, et al. Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridisation after universal DNA amplification. Hum Mol Genet 1993, 11, 1907-1914.
11. Tumilowicz J. J., Nichols W. W., Cholon J. J., Greene A. E. Definition of a continuous cell line derived from neuroblastoma. Cancer Res. 30:1970;2110-2118.
12. Sugimoto T., Tatsumi E., Kemshead J. T., et al. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J Natl Cancer Inst. 73:1984;51-57.
13. Donti E, Longo L, Tonini GP, et al. Cytogenetic and molecular study of two human neuroblastoma cell lines. Cancer Genet Cytogenet 1988, 30, 225-231.
14. Brodeur G. M., Sekhon G. S., Goldstein M. N. Chromosomal aberrations in human neuroblastomas. Cancer. 40:1977;2256-2263.
15. Cowell J. K., Rupniak H. T. Chromosome analysis of human neuroblastoma cell line showing double minutes and an aberration involving chromosome 1. Cancer Genet Cytogenet. 9:1983;273-280.
16. Reynolds CP, Biedler JL, Spengler BA, et al. Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst 1986, 76, 375-387.
17. Amler L. C., Corvi R., Praml C., et al. A reciprocal translocation (1;15)(p36.2;q24) in a neuroblastoma cell line is accompanied by DNA duplication and may signal the site of a putative tumor suppressor gene. Oncogene. 10:1995;1095-1101.
18. Muresu R., Casciano I., Volpi E. V., Sinsicalco M., Romani M. Cytogenetic and molecular studies on the neuroblastoma cell line NGP: identification of a reciprocal t(1;15) involving the "consensus region" 1p36.1. Genes Chrom Cancer. 13:1995;66-71.
19. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
20. du Manoir S, Schröck E, Bentz M, et al. Quantitative analysis of comparative genomic hybridization. Cytometry 1995, 19, 27-41.
21. Schuuring E, Verhoeven E, Van Tinteren H, et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992, 52, 5229-5234.
22. Schuuring E., Verhoeven E., Mooi W. J., Michalides R. J. A. M. Identification and cloning of two overexpressed genes U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. 7:1992;1001-1007.
23. Cheng NC, Van Roy N, Chan A, et al. Analysis of chromosome 1p deletions and N-myc activation in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region. Oncogene 1995, 10, 291-297.
24. Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene. 59:1995;83-86.
25. Van Roy N., Forus A., Myklebost O., Cheng N., Versteeg R., Speleman F. Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP. Cancer Genet Cytogenet. 82:1995;151-154.